MOMAGPNONA01NCT07881159
National Registry of Noonan Syndrome
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial sites reduced: 35 → 13 locations
- Site details revised at 2 of 13 sites
- Minor Study sites: 35 to 13
- Study title shortened, about 5 words
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Establish a national disease registry
Timeframe: 5 years
Describe the clinical characteristics of a large population of individuals with Noonan syndrome and the possible genotype-phenotype correlation
Timeframe: 5 years
Provide an online platform for healthcare professionals to report demographic and clinical information on patients with Noonan syndrome
Timeframe: 5 years
Secondary (3)
Evaluate growth curves and any short- and/or long-term complications in individuals with Noonan syndrome, with or without growth hormone (GH) treatment
Draft specific recommendations for the long-term follow-up of these patients
Facilitate future clinical trials in individuals with this condition
Arms and interventions
People of any age and sex with Noonan syndrome confirmed by a genetic test
Sites
13 sites in 1 country